The thiol-disulfide oxidoreductase ERp57 is a soluble protein of the endoplasmic reticulum and the closest known homologue of protein disulfide isomerase. The protein interacts with the two lectin chaperones calnexin and calreticulin and thereby promotes the oxidative folding of newly synthesized glycoproteins. Here we have characterized several fundamental structural and functional properties of ERp57 in vitro, such as the domain organization, shape, redox potential, and the ability to catalyze different thiol-disulfide exchange reactions. Like protein disulfide isomerase, we find ERp57 to be comprised of four structural domains. The protein has an elongated shape of 3.4 ؎ 0.1 nm in diameter and 16.8 ؎ 0.5 nm in length. The two redox-active a and a domains were determined to have redox potentials of ؊0.167 and ؊0.156 V, respectively. Furthermore, ERp57 was shown to efficiently catalyze disulfide reduction, disulfide isomerization, and dithiol oxidation in substrate proteins. The implications of these findings for the function of the protein in vivo are discussed.
The thiol-disulfide oxidoreductase ERp57 is a soluble protein of the endoplasmic reticulum and the closest known homologue of protein disulfide isomerase. The protein interacts with the two lectin chaperones calnexin and calreticulin and thereby promotes the oxidative folding of newly synthesized glycoproteins. Here we have characterized several fundamental structural and functional properties of ERp57 in vitro, such as the domain organization, shape, redox potential, and the ability to catalyze different thiol-disulfide exchange reactions. Like protein disulfide isomerase, we find ERp57 to be comprised of four structural domains. The protein has an elongated shape of 3.4 ؎ 0.1 nm in diameter and 16.8 ؎ 0.5 nm in length. The two redox-active a and a domains were determined to have redox potentials of ؊0.167 and ؊0.156 V, respectively. Furthermore, ERp57 was shown to efficiently catalyze disulfide reduction, disulfide isomerization, and dithiol oxidation in substrate proteins. The implications of these findings for the function of the protein in vivo are discussed.
After translocation into the lumen of the endoplasmic reticulum (ER), 1 newly synthesized proteins fold and oligomerize before they are transported further in the secretory pathway. Covalent modifications, such as N-linked glycosylation and signal peptide cleavage, play an important role in protein maturation in the ER. In addition, the formation of disulfide bonds is often essential. By establishing covalent intra-and intermolecular cross-links, disulfide bonds allow a more productive folding of many polypeptides and provide a higher overall stability. The steady production of new proteins in the ER and the continued oxidation of cysteine thiols is supported by a constant supply of oxidizing equivalents.
In recent years, the molecular mechanisms of disulfide bond formation in the periplasm of Gram-negative bacteria and in the ER of Saccharomyces cerevisiae have been thoroughly characterized (reviewed in Ref. 1) . In the ER of animal cells, disulfide bond formation is less well understood. Still, protein disulfide isomerase (PDI), an essential and well characterized ER resident enzyme, is known to interact with various substrates and to catalyze their oxidation, reduction, and isomerization (reviewed in Ref. 2) . Recently, it has become evident that PDI obtains the oxidizing equivalents that it uses for oxidation of cysteine thiols from Ero1, a membrane-associated FAD-binding ER protein that transfers electrons from PDI to molecular oxygen (3, 4) . In S. cerevisiae, an additional protein, Erv2p, performs a similar function to that of Ero1 (4, 5) . Although orthologues of Erv2p do not seem to exist in higher eukaryotes, two human isoforms of Ero1 have been identified, Ero1␣ and Ero1␤ (6, 7) .
A number of mammalian PDI-like ER proteins are known (8) , including ERp57, ERp72, P5, PDIR, PDIp, TMX, ERp44, and the more recently described ERdj5/JPDI (9, 10), ERp18/ ERp19 (11, 12) , and EndoPDI/ERp46 (11, 13) . They all contain one or more domains with sequence homology to thioredoxin, a cytosolic reductase. The redox activity of thioredoxin-like domains is provided by two cysteine residues present in a characteristic CXXC sequence motif. For several of the proteins mentioned above, the redox activity has been characterized in vitro (12, 14, 15) , but in many cases the in vivo function is less well studied. Few endogenous substrates have been identified, and it is often not clear whether these PDI homologues serve a role in reduction, oxidation, or disulfide isomerization in the ER.
Cell biological and biochemical studies have revealed ERp57 to be a component of the calnexin/calreticulin chaperone system that promotes the folding and quality control of glycoproteins in the ER (reviewed in Ref. 16 ). Calnexin (CNX) and calreticulin (CRT) are homologous lectin chaperones that bind to the monoglucosylated glycan present on newly synthesized glycoproteins. Upon association with CNX and CRT (17, 18) , ERp57 acts as a thiol-disulfide oxidoreductase for proteins carrying N-linked glycans. Transient disulfide-linked intermediates between ERp57 and nascent and newly synthesized glycoproteins have been observed in vivo (19) . In vitro, the ERp57-enhanced oxidative refolding of RNase B, the glycosylated variant of RNase A, is critically dependent on its interaction with CNX and CRT (20) . Two well characterized functions of ERp57 are as an important component of the major histocompatibility complex (MHC) class I peptide loading complex (21, 22) and in the folding of influenza hemagglutinin (23) .
From the recently solved three-dimensional structures of the CRT P-domain and the luminal domain of CNX (24, 25) , it was revealed that both chaperones contain a globular lectin domain with a long, protruding arm-like extension, referred to as the P-domain. The site of interaction with ERp57 has been mapped to the outermost tip of the P-domain in both CNX and CRT (26 -28) . The exact position of the binding site in ERp57 for the two lectin chaperones remains to be elucidated.
The overall sequence identity at the amino acid level between ERp57 and PDI is 33% (8) , making ERp57 the closest known homologue of PDI. The latter protein comprises four thioredoxin-like domains, two of which (denoted a and a) are redox-active and contain a CGHC motif, whereas the other two domains (denoted b and b) are redox-inactive and are devoid of CXXC motifs. The domains are arranged in the order a-b-b-a. In addition, PDI has an acidic C-terminal sequence. ERp57 lacks this negatively charged region, and its "QDEL" ER retrieval signal is directly preceded by the region corresponding to the PDI a domain (8) . NMR structures of the a and b domains in PDI show a thioredoxin fold for both (29, 30) , and it is thus likely that the a and b domains also exhibit this fold. At present, the spatial organization of the four thioredoxin-like domains in PDI is unknown.
For ERp57, the information regarding the three-dimensional structure is limited to NMR assignments of the a domain (31) , and like PDI, ERp57 contains two CGHC active-site sequence motifs. Overall, the protein remains poorly characterized at the molecular level. Here we have investigated the biophysical and enzymatic properties of ERp57 to gain a more detailed understanding of structural and functional aspects of this thioldisulfide oxidoreductase.
MATERIALS AND METHODS
Protein Expression and Purification-Full-length human ERp57, human PDI, Escherichia coli DsbA, E. coli thioredoxin (Trx), and human CRT were prepared as described previously (26, (32) (33) (34) . Bovine insulin was from Sigma. The ERp57 a and a domains were expressed and purified like full-length ERp57 (26) , except for the absence of reducing agent in all buffers used. The protein sequence for the human ERp57 a domain includes residues 1-112 and residues 353-473 for the ERp57 a domain. In this study, all ERp57 residue numbers refer to the human sequence after cleavage of the predicted signal peptide to generate the mature N terminus beginning with the sequence Ser 1 -Asp 2 -Val 3 . Gene products encoding the a and a domains were amplified by PCR and cloned into a pRSET A-derived E. coli expression vector (35) . Protein expression from this vector results in the production of a fusion protein with an N-terminal 17-amino acid affinity tag containing a hexahistidine sequence. The correct sequence of both constructs was verified by DNA sequencing.
Protein Concentration Determination-The concentration of all proteins used in this study was determined from their absorbance at 280 nm by using the molar extinction coefficients calculated by the method of Gill and von Hippel (36 4 /KOH, 25 mM NaCl, 10 mM ␤-mercaptoethanol, pH 7.0, at 37°C at the concentrations of ERp57 and the specific protease indicated in Fig. 1 . For trypsin, chymotrypsin, and elastase (Roche Applied Science), the digestions were stopped by the addition of phenylmethylsulfonide fluoride to 5 mM and in the case of thermolysin (Roche Applied Science) by adding EDTA to 5 mM. After addition of electrophoresis sample buffer, the digests were analyzed on SDS-15% PAGE (w/v), blotted onto a polyvinylidene fluoride (PVDF) membrane, and subjected to N-terminal sequencing.
Circular Dichroism Measurements-CD measurements were performed on a Jasco J-810 spectropolarimeter in a 1-mm path length cell at 25°C. Spectra were averaged from 10 scans, and the buffer base line was subtracted. All proteins (6 -11 M) were in a buffer containing 100 mM KH 2 PO 4 /KOH, 25 mM NaCl, pH 7.0. ERp57 was reduced with 10 mM ␤-mercaptoethanol and oxidized with 2 mM GSSG. The a and a domains were reduced with 1 mM DTT and oxidized with 1 mM GSSG. Reduction and oxidation was performed by dialyzing against the respective buffers overnight. The spectra for the ERp57 a and a domains were not corrected for the presence of the unstructured N-terminal 17-amino acid affinity tag.
Quantification of Free Thiol Groups-Analysis of free thiol groups in ERp57 by Ellman's reagent 5,5Ј-dithiobis-2-nitrobenzoic acid was carried out at protein concentrations of 30 M and 5,5Ј-dithiobis-2-nitrobenzoic acid concentrations of 0.3 mM in 80 mM sodium phosphate, pH 8.0, 1 mM EDTA, 2% w/v SDS. After incubation for 15 min at room temperature, the absorbance at 412 nm was recorded using an extinction coefficient of 13,600 M Ϫ1 cm Ϫ1 per free thiol (37) . Analytical Ultracentrifugation-Sedimentation velocity and equilibrium analysis of ERp57 and sedimentation velocity analysis of a mixture of ERp57 and CRT were performed on a Beckman Instruments Optima XL-I Analytical Ultracentrifuge. The cells were equipped with sapphire windows and 12-mm aluminum-filled Epon double sector centerpieces.
Sedimentation velocity runs for ERp57 were carried out at 20°C and 50,000 rpm with patterns being acquired every 7 s. Sedimentation boundaries were analyzed using time derivative analysis as described previously (38, 39) and with the recently developed SEDANAL software for the analysis of interacting systems (40) . Uncertainties in the fitted parameters were obtained using the bootstrap with replacement method. A stock solution of ERp57 at ϳ2 mg/ml was dialyzed for at least 16 h against 100 mM KH 2 PO 4 /KOH, pH 7.0, 25 mM NaCl, containing 2 mM dithio-1,4-threitol (DTT). Solutions of ERp57 in the range 0.1-1.0 mg/ml were prepared using the dialysate as diluent. For this particular buffer, the density and viscosity were calculated with Sednterp to be 1.01141 g/ml and 1.0342 centipoise, respectively. The value of the partial specific volume, v ϭ 0.734 cm 3 /g, was calculated from the amino acid composition of recombinant human ERp57 using the consensus partial volumes of the amino acids (41) . The degree of hydration, ␦ 1 ϭ 0.418 g of H 2 O/g protein, was also calculated from the amino acid composition according to Kuntz and Kauzmann (42) . Hydrodynamic modeling of monomeric ERp57 was performed using the equation of Perrin for an equivalent, hydrated prolate ellipsoid of revolution (43) .
Sedimentation equilibrium runs for ERp57 were carried out at 4°C as described previously (44) . A stock solution of ERp57 at ϳ2 mg/ml was dialyzed for at least 24 h immediately prior to analysis in the same buffer as for sedimentation velocity runs. In addition, a series of dilutions of ERp57 in the range 0.1-1.0 mg/ml were prepared using the dialysate as diluent. Six-channel external loading centerpieces (Beckman Coulter part numbers 366755 and 368115) were used. Optical blank runs were performed both before and after the run at the expected and actual speeds, respectively. Sedimentation equilibrium data were analyzed by global fitting, combined data from three loading concentrations, and two speeds, as described previously (44) .
Interaction studies between ERp57 and CRT were executed by sedimentation velocity at 20°C and 50,000 rpm. Separate stock solutions of ERp57 and CRT at ϳ0.6 mg/ml were simultaneously dialyzed overnight against 100 mM KH 2 PO 4 , pH 7.0, 25 mM NaCl, and 1 mM DTT. To ensure the absence of any oxidized forms of ERp57 in solution, the protein was treated with 10 mM DTT for 1 h immediately prior to the dialysis step. Values of the partial specific volume and hydration of CRT were 0.698 cm 3 /g and 0.502 g of H 2 O/g protein as reported previously (34) . The sedimentation velocity profiles were analyzed with the program SEDANAL to produce the g(s*) patterns and also fit to a 1:1 stoichiometry to obtain estimates of the equilibrium constants.
Redox Equilibrium between the ERp57 a and a Domains and Glutathione-Fluorescence experiments were performed at 25°C on a PTI Quantamaster QM-7/2003 Spectrofluorometer. All buffers used contained 1 mM EDTA and were filtered, degassed, and flushed with argon. Equilibration of the ERp57 a and a domains at different GSH/GSSG ratios in 100 mM KH 2 PO 4 /KOH, 1 mM EDTA, pH 7.0, was performed for at least 15 h at 25°C. A protein concentration of 2 M was used in all experiments. After excitation at 280 nm, the fluorescence intensity at 350 nm, the wavelength at which the maximal difference between the emission of oxidized and reduced protein was observed, was recorded for 20 s and averaged. To determine the equilibrium constant K eq for the ERp57 a and a domain/glutathione system, the fluorescence emission at [GSH] 2 /[GSSG] ratios from 10 Ϫ5 to 1 M was measured. This was achieved by varying the GSH concentration between 0.03 and 11 mM at a constant GSSG concentration of 0.1 mM. The completely reduced protein was measured at 10 mM GSH and the completely oxidized protein at 0.1 mM GSSG. Ellman's reagent was used as described above to verify that the protein was completely oxidized. The measured fluorescence F was plotted against the [GSH] 2 /[GSSG] ratio and fitted according to Equation 1 to obtain F ox , the fluorescence of oxidized and F red , the fluorescence of reduced protein. The relative amount of reduced protein at equilibrium (R), determined with Equation 2, was plotted against the [GSH] 2 /[GSSG] ratio, and the data were fitted according to Equation 1 to obtain K eq . The standard redox potentials of the ERp57 a and a domains were then calculated with the Nernst Equation 3 using the glutathione standard potential EЈ 0GSH/GSSG of Ϫ0.240 V at pH 7.0 and 25°C (45) .
Reductase Assay with Insulin-The catalyzed reduction of insulin by DTT was monitored at different concentrations of various thiol-disulfide oxidoreductases as catalysts by measuring the increase in turbidity at 650 nm (46) . Each assay was performed at 25°C and contained 130 M insulin and different concentrations of catalyst in 100 mM KH 2 PO 4 / KOH, 1 mM DTT, 2 mM EDTA, pH 7.0. The enzymes were pre-incubated in the DTT-containing buffer for 5 min, and the assay was started by the addition of insulin. The onset of aggregation was defined as the time where OD 650 had reached the value of 0.025. The enzyme concentration at which this occurred was plotted against the onset of aggregation in order to obtain a concentration-dependent activity curve for the reductase activity of each oxidoreductase.
Preparation of Scrambled RNaseA-Scrambled RNaseA (scRNaseA) was prepared by reducing and denaturing 70 mg of native RNaseA (natRNaseA) (Sigma) overnight at room temperature in 3 ml of 50 mM Tris/HCl, pH 8.0, 6 M guanidinium chloride, and 150 mM DTT. Next, buffer exchange into 100 mM acetic acid/NaOH, pH 4.0, was obtained by gel filtration on a PD-10 column (Amersham Biosciences). The reduced and denatured RNaseA was diluted to 0.25 mg/ml with 50 mM Tris/HCl, pH 8.5, 6 M guanidinium chloride and subjected to air oxidation for 5 days in the dark. Finally, after concentration, RNaseA was gel-filtrated once again on a PD-10 column into 100 mM acetic acid/NaOH, pH 4.0, and stored at Ϫ20°C. Both after reduction and oxidation the number of free thiols was determined by the Ellman's assay. The scRNaseA preparation lacked free thiols, as well as disulfide-linked dimers as shown by non-reducing SDS-PAGE.
Disulfide Isomerase Assay with Scrambled RNaseA-The isomerase function of ERp57 and its redox-active domains was tested by the ability to reactivate scRNaseA. 40 M scRNaseA was incubated with 10 M (active-site concentration) of a given thiol-disulfide oxidoreductase previously reduced with an equimolar concentration of DTT. The isomerase reaction was performed in 100 mM KH 2 PO 4 /KOH, 2 mM EDTA, 10 M DTT, pH 7.0, at 25°C. At various time points, 100-l samples were taken from the reaction and added to 300 l of 4 mM cCMP, and the hydrolysis of cCMP was followed on a Cary 3E UVvisible spectrophotometer for 3 min at 296 nm. The hydrolysis rate of cCMP catalyzed by 40 M natRNaseA was set to 100% activity, and all other samples were expressed as a percentage of this value.
Construction of Plasmids for Periplasmic Protein Expression-The plasmid pDsbA3 (47) was used to generate constructs in which the DsbA signal sequence was fused to the respective oxidoreductase. Expression from this plasmid is under the control of the trc promoter/lac operator. The cDNA regions encoding ERp57 and PDI were amplified by PCR from the plasmids pHisERp57 (26) and pET12PDI (48) , respectively, using the following primers: ERp57OxF, 5Ј-GGTACTAGTGCG-TCCGACGTGCTAGAACTC, and ERp57OxR, 5Ј-GCAGCCGGATCCT-TAGAG; PDIOxF, 5Ј-AGCGCTAGCGCGGACGCCCCCGAGGAG, and PDIOxR, 5Ј-TACTAGTGCGGACGCCCCCGAGGAG. The resulting PCR products were digested with SpeI and BamHI and cloned into pDsbA3 where the segment encoding mature DsbA had been removed with NheI and BamHI, thus generating the pDsbAERp57 and pDsbAPDI constructs. The ERp57 a domain and bba domain constructs were produced by PCR from the plasmid pDsbAERp57 using the phosphorylated primers ERp57aF, 5Ј-TAAGGATCCCCACGCGCC, and ERp57aR, 5Ј-CTGCTTCTTCAAGTGGCTG; ERp57bbЈaЈF, TACTAGT-GCGGCAGGACCAGCTTCA, and ERp57bbЈaЈR, 5Ј-CCCGGATCCTTA-GAGATCCTCCTG. Next, the resulting PCR fragments comprising the entire vector and the desired regions of the ERp57 gene were blunt-end ligated. The creation of the construct for the secretion of the PDI a domain has been described before (49) . The DsbC construct used in the assay encodes the redox-inactive C98A/C101A variant as a negative control. The correct sequence of all constructs was verified by DNA sequencing.
In Vivo Complementation Assay-E. coli THZ2 cells (50) lacking the bacterial dithiol oxidase DsbA were transformed with the secretory expression plasmid of the oxidoreductase construct to be tested. Expression, correct localization to the periplasm, and processing of the leader peptide was verified for each construct by cell fractionation. Cytosolic and periplasmic fractions were compared on SDS-PAGE, and in certain cases by transfer to a PVDF membrane followed by N-terminal sequencing or detection by an antibody. To obtain the periplasmic fraction, cells grown at 37°C in LB medium supplemented with 100 g/ml ampicillin were induced with 1 mM isopropyl-␤-D-thiogalactopyranoside at OD 600 of 0.6 and grown for 3 h. Next, cells were harvested by centrifugation, and periplasmic proteins were extracted by stirring the cells for 1 h at 4°C in 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mg/ml polymyxin B sulfate. Spheroblasts were pelleted by centrifugation, and the periplasmic fraction remained in the supernatant. Because we did not detect expression of the isolated ERp57 a domain in this system, the triple domain construct of ERp57 bba was used to test the oxidase activity of the ERp57 a domain.
DsbA complementation was analyzed by the recovery of motility of a single colony (51) . 1 l of LB culture inoculated with a single colony of THZ2 cells transformed with an oxidoreductase secretion construct and adjusted to OD 600 ϭ 0.7 was placed in the middle of an LB plate containing 0.3% (w/v) agar. After incubation at 37°C for 24 h, the diameter of the bacterial lawn was compared with that of E. coli THZ2 harboring pDsbA3 as a positive control and DsbC C98A/C101A as a negative control. Additionally, DsbA complementation was analyzed by oxidative inactivation of ␤-galactosidase fused C-terminally to MalF (52) . Streak-outs of overnight cultures containing 100 g/ml ampicillin and transformed with the respective periplasmic expression plasmid were made on LB agar plates supplemented with 0.4% maltose and 40 g/ml 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-gal) and incubated for 24 h at 37°C followed by 6 h at 4°C. DsbA complementation was classified as follows: white colonies (ϩ), pale blue colonies (ϩ/Ϫ), blue colonies (Ϫ).
RESULTS

Determination of Domain Boundaries in ERp57
-As a first characterization of recombinantly expressed full-length ERp57, we subjected the protein to limited proteolysis. This experimental approach not only gives information about domain boundaries but also about the relative stability of individual domains toward proteolysis.
For proteolysis of ERp57 at pH 7.0 and 37°C, we used trypsin, chymotrypsin, elastase, and thermolysin. Each digestion mixture was resolved by SDS-PAGE ( Fig. 1 ) and transferred onto a PVDF membrane, and single bands were excised and N-terminally sequenced. Table I lists the N-terminal sequence obtained for each of the fragments corresponding to the bands indicated in Fig. 1. Fig. 2 shows the sequence positions of the ERp57 fragments obtained by partial digestion, as well as the experimentally determined domain structure of PDI.
Cuts were generated at the expected domain boundaries between b and b and between b and a inferred from a sequence alignment with PDI. All four proteases generated cuts in the sequence region 211-222 between the b and b domains (fragments 1, 4, 11, and 16), whereas trypsin and chymotrypsin cleaved at residues 340 and 341 in a region predicted to connect the b and a domains (fragments 2 and 5). Based on the sequence alignment with PDI and the proposed linker region in PDI deduced from the NMR structures of the PDI a and b domains (30), we expected the linker between these two domains in ERp57 to comprise only residues 109 -111. The short length of this linker likely explains why no cleavage occurred exactly within this region. The closest cut was the one produced by elastase at residue 134 (fragment 7).
The mobility of the proteolytic fragments visible on gels combined with the 12-15-kDa size for a single thioredoxin-like domain enabled us to predict which single, double, and triple domains were present in the different digestion mixtures. The only single domains detected were the a (fragments 3, 6, 12, 13, 17, and 18) and a domains (fragments 2 and 5). The only double and triple domains observed were ba (fragments 1, 4, and 16) and bba (fragment 7), respectively. However, the b domain was rapidly degraded from the N terminus of this triple domain at higher concentrations of protease and longer incubation times (Fig. 1b, fragments 7-10) . At lower concentrations of protease or shorter incubation, a was observed together with b (fragments 1, 4, 11, and 16) , indicating that the pres-ence of the a domain stabilized the b domain to a certain extent. Overall, of the four domains, the a and a domains appeared to be the most resistant and the b domain the least resistant to proteolysis. The b domain could not withstand extended proteolytic cleavage.
For the following experiments performed in this investigation, we used ERp57 a and a domain constructs comprising residues 1-112 and 353-473, respectively. For the a domain construct the position of the C-terminal boundary was based on a sequence alignment with the PDI a domain. The slight Cterminal truncation of the a domain construct was performed to remove the QDEL ER retrieval sequence and a few preceding residues that are likely to constitute a flexible tail. The notion that segment 353-473 corresponds to a properly folded domain is supported by the NMR assignments reported for an a construct comprising residues 349 -468 (31). Furthermore, spectroscopic analysis of our a and a constructs showed that both display typical features of properly folded proteins (see below).
Spectroscopic Analysis of ERp57-To learn more about structural features of full-length ERp57 and its a and a domains, we performed CD and fluorescence spectroscopy under oxidizing and reducing conditions. For all three constructs, the far-UV CD spectrum showed features characteristic of folded proteins of the ␣-␤ type (Fig. 3, a-c) . No noticeable difference in the secondary structure was observed between the oxidized and the reduced states of the full-length protein and the ERp57 a domain (Fig. 3, a and c) , whereas the ERp57 a domain showed minor spectral changes (Fig. 3b) . ERp57 thus differs from PDI in the sense that the oxidized state of the PDI a domain exhibits a far-UV CD spectrum like that of an unfolded protein (48) (see under "Discussion").
The fluorescence emission spectra obtained for the ERp57 a and a domains after excitation at 280 nm showed that both proteins displayed a 1.8-fold higher emission at 350 nm for their reduced versus their oxidized state (Fig. 3, d and e) . This likely resulted from the quenching of their single trytophan residue, positioned immediately N-terminal to the CGHC sequence motif, upon formation of the active-site disulfide. The spectra of the a domain are dominated by the six tyrosines found in this protein (Fig. 3e) .
ERp57 Contains a Structural Disulfide-Besides the four active-site cysteines, ERp57 contains three additional cysteines. Of these, two are found in the a domain (Cys 61 and Cys 68 ), and one is located at the beginning of the b domain (Cys 220 ). Because the potential intra-and/or intermolecular disulfide bonding pattern of these three cysteines is not known, we determined the number of free thiol groups in the protein.
When conducting the assay with oxidized ERp57 under denaturing conditions, only one free cysteine could be detected (data not shown). Therefore, two of the additional cysteines in ERp57 form a structural disulfide. Moreover, when repeating the assay with the a domain, we detected no free cysteines, indicating that a disulfide bridge must be formed by Cys 61 and Cys 68 . This is consistent with the observation that the C 
TABLE I N-terminally sequenced fragments of ERp57 derived
by limited proteolysis The fragment number listed refers to the numbers shown for the different bands in Fig. 1 Insight into the size and molecular shape of ERp57 was obtained from the frictional ratio, f/f 0 , which was determined from the sedimentation coefficient, s 20,w 0 , and the molecular mass ϭ 54.5 kDa (Table II) . These calculations yielded an f/f 0 ϭ 1.24 using a partial specific volume of 0.734 cm 3 /g and a hydration value of 0.418 g of H 2 O/g protein (Table II) . By using these values for the frictional ratio, partial specific volume, and hydration, monomeric ERp57 could be represented with a hydrodynamically equivalent prolate ellipsoid of revolution having an apparent axial ratio a/b ϭ 4.9 Ϯ 0.2 with a length of 16.8 Ϯ 0.5 nm and a diameter of 3.4 Ϯ 0.1 nm (Table II) . Based on this model, the hydrodynamic measurements indicate that the monomeric form of ERp57 is a moderately elongated protein in solution.
We also investigated interactions between ERp57 and fulllength CRT by sedimentation velocity experiments (Fig. 4) . ERp57 and CRT were mixed in various ratios and analyzed with the program SEDANAL to fit to a heterologous 1:1 stoichiometry of the complex (Fig. 4) . A global fit to four data sets over a range of concentrations gave a value of K d ϭ 2.56 Ϯ 0.01 M. A value of s 20,w ϭ 4.6 Ϯ 0.2 S for the complex of CRT and ERp57 was also obtained from the fits (Table II) . By using this value, the ERp57-CRT complex can be represented with a hydrodynamically equivalent prolate ellipsoid of revolution with a length of 32.7 Ϯ 3.0 nm and diameter of 3.4 Ϯ 0.2 nm. Previous studies on free CRT (34) showed that this protein is highly elongated with a length of 29.8 nm and a diameter of 2.4 nm. Thus, shape analysis for the ERp57-CRT system suggests that the complex forms with a partially overlapping geometry, probably involving conformational changes in both proteins.
Determination of Equilibrium Redox Potentials for ERp57 a and a-As a first means to characterize the redox activity of ERp57, we determined the standard redox potentials for the redox-active a and a domains. Although the redox potential for a given oxidoreductase does not necessarily reveal the redox function of the protein in the living cell, it often provides valuable information about the preferred redox reaction.
By using fluorescence spectroscopy, the redox equilibrium of the ERp57 a and a domains was analyzed at different GSH/ GSSG ratios. The increase in fluorescence emission at 350 nm upon reduction was followed after excitation at 280 nm (Fig. 3,  d and e) . Thus, when ERp57 a and a were incubated in the presence of 0.1 mM GSSG and varying concentrations of GSH (0.03-11 mM) under the exclusion of oxygen, the relative amounts of oxidized and reduced protein at equilibrium could be determined from a fit of the experimental data to Equation 1 (see "Materials and Methods") (Fig. 5, a and b) . By this method, the equilibrium constant, K eq , for the ERp57 a/glutathione system was found to be 3.3 Ϯ 0.4 and 1.5 Ϯ 0.1 mM for the ERp57 a/glutathione system. The standard redox potentials for the ERp57 a and a domains were calculated from the Nernst equation by using the glutathione standard potential of Ϫ0.240 V at pH 7.0 and 25°C (45) and Equation 2 (see "Materials and Methods"). Like this, the standard redox potential for ERp57 a was determined to be Ϫ0.167 V and that for ERp57 a to be Ϫ0.156 V. These values are comparable with the redox potential of Ϫ0.175 V determined for PDI (53) .
Disulfide Reductase Activity of ERp57-PDI is a remarkably versatile enzyme exhibiting reductase, isomerase, and oxidase activities. Although not the only determining factor, the similarity in redox potentials between PDI and ERp57 a and a could indicate similar redox activities. The reductase and isomerase activity of ERp57 in vitro has been addressed previously (54 -57) . However, a comprehensive quantitative analysis of the catalytic activity of ERp57 in comparison to other thioldisulfide oxidoreductase is lacking. Therefore, we decided to investigate whether ERp57 is endowed with the same broad catalytic abilities as PDI by comparing ERp57 to PDI and other well known thiol-disulfide oxidoreductases. We employed assays to probe disulfide reductase, isomerase, and dithiol oxidase activity.
For the reductase activity, we made use of the fact that insulin aggregates upon reduction by DTT. The resulting turbidity of the protein solution can be measured by detecting the optical density at 650 nm (46) . To compare the reductase efficiency of ERp57 with that of PDI and other thiol-disulfide oxidoreductases, we defined the onset of aggregation as the time point where OD 650 exceeded a value of 0.025 (final OD 650 ϭ 1.4 -1.8). For the uncatalyzed reaction, this value was reached after 40 min.
Wide concentration ranges were tested for each oxidoreductase and plotted against the time for onset of aggregation (Fig.  6) . By comparing how much catalyst was required to halve the uncatalyzed time of aggregation onset to 20 min, a relative measure of the reductase efficiency was obtained (Fig. 6, dotted  line) . Quantified in this way, ERp57 proved to be 20 times less efficient than PDI as a reductase (0.8 M of ERp57 needed versus 0.04 M of PDI). However, ERp57 was 5 times more efficient than DsbA, the bacterial oxidase, and only 2 times less efficient than thioredoxin, the bacterial cytosolic reductase.
Disulfide Isomerase Activity of ERp57-To characterize the isomerase activity of ERp57, we used a variant of a well established assay based on the reactivation of disulfide-scrambled RNaseA. The catalyzed isomerization of 40 M scrambled scRNaseA to natRNaseA was followed over a period of 8 h in the presence of catalytic amounts of reduced PDI, ERp57, or the ERp57 a and a domains. To obtain a measure of isomerase activity, samples were collected at different time points, and the rate of cCMP hydrolysis by reactivated RNaseA was determined and expressed as a percentage of the hydrolysis rate obtained with 40 M natRNaseA (Fig. 7) .
Reactivation of scRNaseA to the wild-type level was achieved within ϳ3 h by using 5 M PDI. With the same concentration of ERp57, scRNaseA could only be rescued to ϳ60% of the native level after 8 h. When using 5 M of each of the ERp57 a and a domains, which corresponds to 5 M full-length ERp57 in active-site concentration, the reactivation level reached ϳ30%. In a control experiment, it was verified that the individual a and a domains were both active in our assay (data not shown).
To get a second measure of the disulfide isomerase activity for the different proteins in our assay, we determined the initial rate of catalysis. Here we obtained values for the initial reactivation rate of scRNaseA of greater than or equal to 1.11 M/min for PDI, 0.16 M/min for ERp57, and 0.05 M/min for the ERp57 a and a domains, compared with 4.8 ϫ 10 Ϫ3 M/min for the background reaction (5 M DTT). Therefore, compared with ERp57, the initial rate of reactivation by PDI is at least 7 times faster, while the rate obtained for the mixture of the a and a domains is 3 times slower. The uncatalyzed isomerization reaction is 33 times slower than the ERp57-catalyzed reaction. Taken together, the results of the isomerase assay indicated that although ERp57 does possess activity, it is by far not as efficient as PDI. When mixed, the two separate redoxactive domains did not possess the same isomerase activity as the full-length protein.
Dithiol Oxidase Activity of ERp57-To investigate a potential oxidase activity of ERp57, the existence of two distinct and non-interacting pathways for disulfide bond formation in the periplasm of Gram-negative bacteria was exploited. In E. coli, separate enzymes perform different oxidoreductase functions. DsbA functions as the oxidase of protein thiols, itself in turn being reoxidized by DsbB, which obtains oxidizing equivalents from ubiquinone Q 8 . On the other hand, DsbC performs reductase and isomerase functions. DsbC is kept in a reduced state by DsbD, which in turn is reduced by thioredoxin (for reviews see Refs. 1 and 58).
To test oxidase activity, the ability of periplasmically expressed ERp57, PDI, and various domains of both proteins to complement DsbA deficiency in THZ2, an E. coli strain that lacks DsbA, was analyzed by two phenotypic characteristics. One assay depends on a test of bacterial motility based on the DsbA-dependent folding of the P-ring subunits of the flagellar motor (51) . The other assay involved a blue/white screening that relies on the oxidative inactivation of ␤-galactosidase partially located to the periplasm. This assay probes the DsbA-dependent introduction of inactivating disulfide bonds into a ␤-galactosidase-MalF fusion protein (52, 59 ). Thus, colonies of E. coli that lack a periplasmic oxidase turn blue on LB-plates containing X-gal. As a negative control protein we used a redoxinactive DsbC variant in which the two active-site cysteines had been mutated to alanines (DsbC C98A/C101A), and as a positive control DsbA itself was exported to the periplasm. Periplasmic expression of all proteins was ensured by cloning each construct in-frame with the DsbA leader peptide and was verified by cell fractionation. The assays were performed in the absence of the inducer isopropyl-␤-D-thiogalactopyranoside, whereby protein expression results from a leaky promoter. Thus, approximately the same levels of expression are observed for different constructs (49) .
The results showed that the ability of bacteria to swarm on top of a soft agar plate and form a bacterial lawn was restored in THZ2 cells transformed with the periplasmic expression plasmids of ERp57, the ERp57 a domain, and the ERp57 bba triple domain (Table III) . The latter was used in place of the ERp57 a domain, because we did not observe periplasmic expression of the ERp57 a domain. PDI and the PDI a domain, both known to act as oxidases (49, 60) , also restored bacterial swarming. Equivalent results were obtained with the blue/ white assay (Table III ). In conclusion, ERp57 was able to act as an oxidase in the environment of the bacterial periplasm, and both redox-active domains of ERp57 could compensate for the absence of DsbA.
DISCUSSION
Our investigation of various biophysical and biochemical properties of ERp57 provides new insight into the structure of the molecule, and we show that ERp57 is a versatile redox enzyme. In many respects, it is similar to its closest homologue, PDI, but significant differences in redox activity were also observed. Our findings give a better understanding of ERp57 at the molecular level, and have implications for the function of the protein in vivo.
The limited proteolysis experiments provided information about domain boundaries and showed that like PDI, ERp57 contains four structural domains. Together with previously published data on domain boundaries in PDI (61) (62) (63) , and the sequence similarity between the two proteins, our results allow an estimate of the domain boundaries for the four thioredoxinlike domains in ERp57. Based on this analysis, we have generated the following ERp57 domain constructs in E. coli: a, residues 1-112; b, residues 108 -218; b, residues 219 -352; and a, residues 353-473. The domain boundaries are in agreement with those proposed recently by Alanen et al. (64) , who based their assignments primarily on sequence alignments between known ER thiol-disulfide oxidoreductases.
For the b and b domain constructs, our NMR data show that these proteins give rise to well dispersed NMR signals indicative of defined three-dimensional structures in solution. 2 For the redox-active a and a domains, it is noteworthy that neither seemed to undergo significant structural changes upon formation of the active-site disulfide bond as judged by far-UV CD spectroscopy (Fig. 3, b and c) . Thus, both domains retained spectra characteristic of folded, globular proteins. This is in contrast to the PDI a domain, where the oxidized form exhibits a far-UV CD spectrum much like that of an unfolded protein (48) . A destabilization of the oxidized form in comparison to the reduced form has also been observed in other thiol-disulfide oxidoreductases such as DsbA (20, 65) , ERp18 (12) , and the PDI a domain (12) .
To obtain insight into the hydrodynamic properties of ERp57, the protein was analyzed by analytical ultracentrifugation. Results from sedimentation velocity measurements showed that ERp57 is an elongated molecule with a length of 16.8 Ϯ 0.5 nm and a diameter of 3.4 Ϯ 0.1 nm (Table II) . These dimensions make it unlikely that the four domains pack closely into the shape of a pyramid-like structure. Most interesting, FIG. 5 . Redox equilibrium of ERp57 a and a domains with glutathione. The fraction of reduced ERp57 a domain (a) and ERp57 a domain (b) at pH 7.0 and 25°C was determined by fluorescence spectroscopy after incubation of the proteins for at least 16 h in a buffer containing 0.1 mM GSSG and varying concentrations of GSH (0.03-11 mM). After excitation at 280 nm, fluorescence emission was recorded at 350 nm, the data were normalized, and the fraction of reduced protein was plotted against the [GSH] 2 /[GSSG] ratio. The equilibrium constant was determined, and the data were normalized by fitting them according to Equation 1 (see under "Materials and Methods"). After nonlinear regression, a value of K eq ϭ 3.3 mM was obtained for the ERp57 a domain (correlation coefficient, 0.989) and a value of K eq ϭ 1.5 mM was found for the ERp57 a domain (correlation coefficient, 0.998). At various time points samples were taken from the reaction, and the RNaseA activity was followed by the hydrolysis of cCMP for 3 min at 296 nm. The initial hydrolysis rate of cCMP for 40 M natRNaseA (E) was set to 100% RNaseA activity, and all other initial rates were expressed as a percentage of this activity. ᭛, 40 M scRNaseA in the presence of 10 M DTT (no catalyst added). recent ultracentrifugation studies from Gilbert's lab indicate that PDI is also likely to be an elongated molecule in solution. 3 Somewhat surprisingly, the sedimentation equilibrium analysis showed a reversible self-association of ERp57 into trimers and hexamers in solution in the presence of 2 mM DTT. The dissociation constants for the monomer-trimer and the trimerhexamer equilibria were determined to 1700 M 2 and 14 nM, respectively. The high value of the dissociation constant for the monomer-trimer equilibrium suggests that these ERp57 oligomers are unlikely to be physiologically relevant. Moreover, no oligomeric form of the protein has been observed in vivo so far.
Sedimentation studies were extended to characterize the interaction between ERp57 and full-length CRT in solution. Analysis of a mixture of ERp57 and CRT revealed that these proteins form a 1:1 molar complex with a K d in the low micromolar range in agreement with results obtained for the ERp57/ CRT P-domain system. By using isothermal titration calorimetry, we have shown previously that the CRT P-domain forms a 1:1 complex with ERp57 in solution (26, 27) . The dissociation constants determined between ERp57 and two different recombinant forms of CRT P-domain were found to be 9.1 Ϯ 3.0 and 5.1 Ϯ 0.7 M (26, 27). Although other contact sites in CRT cannot be ruled out entirely at this point, the studies suggest that the interaction between ERp57 and CRT is mediated exclusively through the CRT P-domain. This is also consistent with the apparent molecular shape of the ERp57-CRT complex as determined by hydrodynamic analysis (Table II) . That ERp57 and CRT form a 1:1 complex in vitro is in agreement with findings showing that a heterodimeric complex of the two proteins isolated from canine pancreatic microsomes runs at ϳ140 kDa on a native gel and that a complex of similar mobility by SDS-PAGE can be observed after cross-linking of the two proteins in semi-permeabilized mammalian cells (18) .
Characterization of the redox properties of ERp57 showed that the protein is a versatile redox enzyme. For the a and a domains, we determined the equilibrium constants with glutathione to 3.3 and 1.5 mM, respectively. This translates into redox potentials of Ϫ0.167 V for the a domain and Ϫ0.156 V for a. In comparison, thioredoxin, the bacterial cytoplasmic reductase, has a redox potential of Ϫ0.270 V (66), and DsbA, the bacterial oxidase, has a value of Ϫ0.122 V (67). The intermediate values found for the ERp57 redox-active domains are thus closer to the redox potential of Ϫ0.175 V determined for PDI (53) and the equilibrium constants of 0.7 mM for the PDI a domain and of 1.9 mM for PDI a domain (68) , all determined with GSH/GSSG as a reference.
Like PDI, ERp57 was capable of catalyzing reduction, isomerization, and oxidation. The reductase activity of the protein was close to that exhibited by thioredoxin and was clearly higher than that of DsbA (Fig. 6) . The initial rate of isomerase catalysis by ERp57 was found to be 33 times faster than the DTT background reaction. However, PDI performed both of these redox functions more efficiently than ERp57. In both cases, the difference is consistent with the finding that PDI, unlike ERp57, has been shown to possess peptide binding activity, a function that is mediated by its b domain (69) . The b domain of PDI has been demonstrated to be essential for binding of scRNaseA, as the replacement of the PDI b domain by the ERp57 b domain abolishes binding (70) . Thus, PDI likely catalyzes reduction and isomerization more efficiently than ERp57 by directly interacting with its substrates through the b domain, a function that seems to have been lost in ERp57, perhaps in exchange for the ability to associate with CNX and CRT.
Important insight into the function of ERp57 has come from the observation that acceleration of disulfide-coupled refolding of reduced RNaseB catalyzed by ERp57 was shown to be dependent on its interaction with CNX and CRT (71) . In this context, it is interesting to note that ERp57, unlike PDI, seemingly does not catalyze refolding of reduced RNaseA or lysozyme (56) . However, this observation might well be a result of a weaker, as opposed to absent, oxidase and/or isomerase activity of ERp57 compared with PDI. ERp57 probably compensates for its apparent inability to interact directly with substrates through backbone contacts (resulting in a lower redox activity in comparison to PDI when tested in vitro on non-glycosylated proteins) by depending on CNX and CRT to expose the protein directly to its glycoprotein substrates.
The function of the PDI b domain likely explains to a large extent why the two isolated redox-active PDI a and a domains do not provide the same efficiency of isomerization as the intact protein (48, 72) . We observed a similar effect in ERp57, where the combination of the separate a and a domains did not isomerize scRNaseA as efficiently as the full-length protein (Fig. 7) . Features of the protein other than those of the isolated redox-active domains are needed for effective isomerization also by ERp57. The molecular characteristics underlying this effect are not clear, but simply the presence of two active sites on the same molecule could provide an explanation for the higher isomerase efficiency observed for the full-length protein.
In addition, a weak peptide-binding activity of either ERp57 b or b cannot be ruled out.
As an assay for oxidase activity, we investigated the ability of ERp57 to complement DsbA deficiency in the periplasm of E. coli. Previously, the efficient restoration of the DsbA ϩ phenotype in the dsbA Ϫ THZ2 strain has been shown to correlate with the redox potential so that thioredoxin variants with an E 0 Ј higher than Ϫ0.221 V showed complementation (49) . Our results demonstrated that all three ERp57 constructs tested were able to act as oxidases in this assay. This result is in accordance with the determined redox potentials for the a and a domains. Recently, full-length ERp57 from Caenorhabditis elegans was also found to complement DsbA deficiency (73) . In addition, the ERp57 a domain can catalyze the oxidation of a model peptide substrate in vitro (74) . Our results also indicate that all active sites of ERp57 as well as the PDI a domain are substrates of DsbB.
Although we have characterized the different redox activities performed by ERp57 in vitro, the question of its redox function in vivo remains open. The protein has been shown to reduce partially folded MHC class I molecules in vitro (75) . Based on this study, it was proposed that ERp57 could play a role in 3 H. F. Gilbert, personal communication. 
reducing intrachain disulfides in MHC class I molecules targeted for degradation. Because ERp57 is an important component of the peptide loading complex, the protein would be positioned favorably to perform this function. A similar reductase activity has been proposed for PDI in retrotranslocation of the cholera toxin A chain (76) . In addition to its potential reductase function, ERp57 likely catalyzes disulfide-coupled glycoprotein folding directly in vivo. The finding that ERp57 forms transient mixed disulfides with productively folding glycoprotein substrates of CNX and CRT argues in favor of this view (77) . Furthermore, ERp57 has been implicated in disulfide bond isomerization of the MHC class I heavy chain in the peptide loading complex (78) .
There is no indication so far that disulfide-exchange reactions with Ero1 regulate the redox function of ERp57, as observed for PDI. Ero1 overexpression seems to have no effect on the redox state of ERp57, and intermolecular disulfides between Ero1 and ERp57 have not been detected (79) . Although this could be due to technical difficulties in trapping and revealing Ero1-ERp57 mixed disulfide complexes, the presence of an Ero1-independent system for ERp57 reoxidation cannot be ruled out. However, two recent studies (79, 80) show that in the ER of mammalian tissue-culture cells ERp57 is found in the reduced state. Although perhaps a cell type-dependent phenomenon, this finding indicates that ERp57 might not react as an oxidase in vivo and consequently not depend on a system for its reoxidation. Further studies are needed to clarify this important point.
